LASA Supergenerics' board has approved its Q3 FY26 financial results, which highlight the severe impact of a factory fire in May 2025. This incident has completely halted production at its key manufacturing unit.

Crucially, the affected assets were uninsured, leading to substantial exceptional losses: inventories worth ₹12.74 Cr, property and equipment of ₹7.00 Cr, and other expenses of ₹0.84 Cr.

The company is exploring alternative manufacturing options as operations remain suspended.

This operational standstill and uninsured losses point to a very challenging period for the company.